MENSINK KEVIN L 4
4 · ENTELLUS MEDICAL INC · Filed Oct 18, 2017
Insider Transaction Report
Form 4
MENSINK KEVIN L
VICE PRESIDENT, MARKETING
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2017-10-16$1.24/sh−10,000$12,400→ 61,400 totalExercise: $1.24Exp: 2023-04-08→ Common Stock (10,000 underlying) - Sale
Common Stock, $0.001 par value
2017-10-16$18.29/sh−10,000$182,903→ 7,500 total - Exercise/Conversion
Common Stock, $0.001 par value
2017-10-16$1.24/sh+10,000$12,400→ 17,500 total
Footnotes (4)
- [F1]Includes 7,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan.
- [F2]These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.64, inclusive. The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- [F4]This option vested as to twenty-five percent (25%) of the shares underlying the option on April 8, 2014, with the remaining shares vesting in 36 substantially equal monthly installments on each monthly anniversary of the grant date thereafter, subject to continued employment or service with the Issuer through each applicable vesting date.